Novartis Weighs Sweetening Buyout Offer As Alcon Shareholders Fight Back

Independent Alcon shareholders have held out for months for a per-share buyout offer that's closer to the price Novartis is paying for the majority of the company. If Novartis wants to avoid an extended legal battle, it may accede to their demands